Neuropathic pain
Somatosensory processing, inhibitory interneurons, and the cellular changes that lock in chronic pain.
- Spinal and brain circuit physiology
- Neuron–glia interactions
- Behavioral readouts of pain states
Team WoojinCollege of Korean MedicineKyung Hee University
Research
Team Woojin studies three linked problems: neuropathic pain circuits, oligodendrocytes and myelin, and the anorexia, cachexia, and metabolic effects of illness and chemotherapy. Plant-derived compounds are tested in the same models.
Focus
Pathological pain is not only a peripheral event. Inhibitory interneurons and the way somatosensory circuits handle incoming signals can fail, and those failures show up in behavior. Team Woojin studies that failure at two scales: the circuit and the cell.
Oligodendrocytes, oligodendrocyte precursor cells, and myelin are part of the same problem. The group treats them as active participants in pain, not as background insulation, and asks when their function drifts in neuropathy.
The therapeutic arm of the lab tests plant-derived compounds in the same models, looking for molecules that restore circuit function rather than only masking symptoms.
| Program | Question | Main approaches |
|---|---|---|
| Pain circuits and glia | How inhibitory interneurons, oligodendrocyte precursor cells, and myelin change somatosensory processing. | Patch clamp, spinal and brain physiology, behavior |
| Chemotherapy neuropathy | How paclitaxel and oxaliplatin alter pain circuits, and which plant-derived compounds reverse that change. | Drug models, natural-product pharmacology |
| Anorexia and metabolism | How cisplatin and diet-related signals affect appetite, muscle, and obesity pathways. | Behavioral models, monoamine pharmacology, chromatography |
Somatosensory processing, inhibitory interneurons, and the cellular changes that lock in chronic pain.
How OPCs, oligodendrocytes, and myelin contribute to pain, a direction developed with collaborators including Prof. María Cecilia Angulo.
Chemotherapy neuropathy, anorexia, cachexia, and metabolic disease, using medicinal compounds as both tools and candidate treatments.
Precise recordings of neuron and glia physiology, used to connect membrane events with circuit change.
Neuropathic pain induced by neurosurgical injury or by chemotherapeutic drugs, read out in behavior.
Extracts and defined metabolites, including work that uses chromatography to follow active constituents.
Noradrenergic and serotonergic contributions to analgesia, including electroacupuncture studies from the group.
Used alongside experiment to map how multi-component medicines may act on pain and metabolic targets.
Markers of astrocytes, microglia, and oligodendrocyte lineage cells in spinal and brain tissue.
Keywords